Henrik Ehlers Wulff

Largest profit: Novo Nordisk Pharmatech A/S (2017) '103,665 DKK

Most equity: Novo Nordisk Pharmatech A/S (2017) '528,953 DKK

Biggest loss: EYE-GO A/S (2017) '12,631 DKK

• Novo Nordisk Pharmatech A/S

  Active

  
  

  Board member (2015-01-23 - 2020-05-15)

  Board member (2009-05-05 - 2012-02-10)

• EYE-GO A/S

  Active

  
  

  Board member (2017-11-15 - 2018-10-12)

• NNE A/S

  Active

  
  

  Board member (2014-03-31 - 2018-03-01)